Related Experiment Video
Updated: May 8, 2026

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
Published on: September 11, 2020
Evolution and molecular characterization of macrolide-resistant Streptococcus pneumoniae in Canada between 1998 and
Aleksandra K Wierzbowski1, James A Karlowsky, Heather J Adam
1Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba R3E 0J9, Canada.
Objectives:
Studies were performed to assess resistance mechanisms, multidrug resistance (MDR), genetic relatedness, serotype distribution, heptavalent pneumococcal conjugate vaccine (PCV7) coverage and pili virulence factors among macrolide-resistant Streptococcus pneumoniae (MRSP) isolated from respiratory samples submitted to hospital laboratories across Canada from 1998 to 2008.
Methods:
Isolates of MRSP (n = 1518) collected by the national surveillance studies CROSS (Canadian Respiratory Organism Susceptibility Study; 1998-2006) and CANWARD (Canadian Ward Surveillance Study; 2007-08) were tested using the CLSI broth microdilution method to establish antimicrobial susceptibilities. PCR was used to detect macrolide resistance genes [mef(A) and erm(B)] and pili virulence factors (type 1 pili and type 2 pili), the Quellung reaction was used to identify serotypes and PFGE was used to determine genetic relatedness.
Results:
The prevalence of MRSP increased from 8% in 1998 to 22% in 2008 (P = 0.0001). MRSP were 51% mef(A) positive, 36% erm(B) positive, 8% dual mef(A) and erm(B) positive and 5% mef(A) and erm(B) negative. Dual mef(A)- and erm(B)-positive isolates increased in prevalence from 3% in 1998 to 19% in 2008 (P = 0.001). The prevalence of PCV7 serotypes (4, 6B, 9V, 14, 18C, 19F and 23F) decreased from 67% in 1998 to 31% in 2008 (P = 0.0072). The prevalence of serotype 19A, a non-PCV7 serotype, increased by 15% from 1998 to 2008; isolates of serotype 19A were MDR, dual mef(A) and erm(B) positive, genetically related by PFGE and associated with the presence of pili virulence factors.
Conclusions:
From 1998 to 2008, respiratory isolates of MRSP in Canada increased significantly due primarily to the emergence and spread of serotypes 6A, 19A and other non-PCV7 serotypes.
Insights
Macrolide-resistant Streptococcus pneumoniae (MRSP) in Canada increased significantly from 1998 to 2008. This rise was driven by non-PCV7 serotypes, particularly 19A, which showed increased multidrug resistance and spread.
Area of Science:
- Clinical Microbiology
- Infectious Diseases
- Antimicrobial Resistance Surveillance
Background:
- Macrolide-resistant Streptococcus pneumoniae (MRSP) poses a significant public health threat.
- Understanding resistance mechanisms and serotype distribution is crucial for effective treatment and prevention strategies.
- Surveillance data from 1998-2008 in Canada provides a decade-long perspective on MRSP trends.
Purpose of the Study:
- To investigate resistance mechanisms, multidrug resistance (MDR), and genetic relatedness of MRSP.
- To determine serotype distribution and heptavalent pneumococcal conjugate vaccine (PCV7) coverage.
- To assess the prevalence of pili virulence factors among MRSP isolates.
Main Methods:
- Analysis of 1518 MRSP isolates from Canadian national surveillance studies (CROSS and CANWARD).
- Antimicrobial susceptibility testing using broth microdilution.
- Detection of macrolide resistance genes (mef(A), erm(B)), pili virulence factors, serotyping (Quellung reaction), and genetic relatedness (PFGE).
Main Results:
- MRSP prevalence increased from 8% to 22% between 1998 and 2008 (P = 0.0001).
- Dual mef(A)- and erm(B)-positive isolates rose from 3% to 19% (P = 0.001), alongside a decrease in PCV7 serotypes (67% to 31%).
- Serotype 19A, a non-PCV7 type, increased by 15% and was associated with MDR, dual resistance genes, genetic relatedness, and pili factors.
Conclusions:
- Significant increase in MRSP respiratory isolates in Canada from 1998-2008.
- Emergence and spread of non-PCV7 serotypes, particularly 19A, are primary drivers of this increase.
- Serotype 19A isolates exhibit concerning characteristics including MDR and presence of virulence factors.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Development of Antibiotic Resistance
Atypical Pneumonia
Evolution of Microbial Genome
Modern Molecular Taxonomy
